Clorox (NYSE: CLX) reported Q3 EPS of $1.31, $0.01 better than the analyst estimate of $1.30. Revenue for the quarter came in at $1.48 billion versus the consensus estimate of $1.48 billion.

Clorox now anticipates fiscal year 2017 diluted EPS from continuing operations in the range of $5.25 to $5.35, an increase of 7 percent to 9 percent

"We delivered solid results on top of double-digit earnings growth in the year-ago quarter," said Clorox Chairman and CEO Benno Dorer. ""I'm pleased with our continued strong volume and sales growth supported by innovation that\'s providing meaningful value to consumers. I\'m also encouraged by the progress we're making in our International business as that team continues to take deliberate actions to rebuild long-term profitability behind its Go Lean strategy."

Dorer added, "Importantly, we're on track to deliver another year of solid sales and earnings growth. We're confident in our strategy and ability to deliver shareholder value over the long term."

For earnings history and earnings-related data on Clorox (CLX) click here.